Opinion: If the new guideline is EpiPen first, access should not be a luxury

I am a physician with good insurance, but every year we have faced higher out-of-pocket cost for my son’s EpiPen.

ARS Pharmaceuticals Announces CEO Succession

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the CompanyDonn Casale, ...

ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Announces CEO Succession

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn Casale, President, Appointed Chief Executive Officer and Directo ...
Zacks Small Cap Research on MSN

OTC Markets Life Sciences Investor Forum: Dan Teleman, CEO, and Eyal Rubin, SVP and CFO, of Nasus Pharma with Zacks SCR's John Vandermosten, CFA

NYSE: NSRX Lily: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next ...

Afghan national who fought with U.S. forces died of allergic reaction in ICE custody

Mohammad Nazeer Paktiawal, 41, suffered “an adverse drug reaction” to an unidentified substance, which triggered anaphylaxis ...